PRESS RELEASE published on 10/30/2025 at 09:00, 3 months 8 days ago Press Release Publication Half-Year Financial Report 2025 Valerio Therapeutics S.A. announces first-half 2025 financial results, discontinuation of clinical activities, and strategic refocus on preclinical R&D. Strengthened financial structure through shareholder advances and capital increases Financial Results Valerio Therapeutics First-half 2025 Preclinical R&D Shareholder Advances
PRESS RELEASE published on 10/30/2025 at 08:58, 3 months 8 days ago Communiqué de presse Mise à disposition du rapport semestriel 2025 Valerio Therapeutics annonce ses résultats financiers du 1er semestre 2025 et fait le point sur ses activités. Renforcement de la R&D préclinique avec les plateformes V-Body et chimie intégrée Résultats Financiers Valerio Therapeutics R&D Préclinique V-Body Chimie Intégrée
BRIEF published on 03/19/2025 at 15:32, 10 months 19 days ago Valerio Therapeutics annonce la composition de son conseil d'administration et leurs fonctions Membres Du Conseil D'administration Valerio Therapeutics Rôles En Entreprise Entreprise Basée À Paris Responsabilités Exécutives
BRIEF published on 03/19/2025 at 15:32, 10 months 19 days ago Valerio Therapeutics Announces Board Members and Their Roles Board Members Valerio Therapeutics Corporate Roles Paris-based Company Executive Responsibilities
PRESS RELEASE published on 03/19/2025 at 15:27, 10 months 19 days ago Inside Information / Other news releases Valerio Therapeutics announces new board members and their positions in other companies as of March 19, 2025 Board Members Positions Valerio Therapeutics Other Companies March 19 2025
BRIEF published on 03/19/2025 at 12:35, 10 months 19 days ago Valerio Therapeutics Board Meeting Decisions Director Changes Shareholder Meeting Share Split Board Resolutions Article Amendments
BRIEF published on 03/19/2025 at 12:35, 10 months 19 days ago Décisions du conseil d'administration de Valerio Therapeutics Assemblée Des Actionnaires Fractionnement Des Actions Changements De Directeur Résolutions Du Conseil D'administration Modifications D'articles
PRESS RELEASE published on 03/19/2025 at 12:30, 10 months 19 days ago Inside Information / Other news releases Valerio Therapeutics Board of Directors convenes a General Meeting with resolutions on director dismissals, co-optation, share division, bylaws amendment, and formalities powers Board Of Directors General Meeting Resolutions Valerio Therapeutics Share Division
PRESS RELEASE published on 03/19/2025 at 12:30, 10 months 19 days ago Informations privilégiées / Autres communiqués Rapport du conseil d'administration de VALERIO THERAPEUTICS pour l'AG mixte des actionnaires du 9 avril 2025 concernant révocations, cooptations, division du nominal des actions et modifications statutaires Cooptation Revocation Valerio Therapeutics AG Mixte Division Du Nominal
BRIEF published on 02/04/2025 at 10:40, 1 year ago Valerio Therapeutics opte pour un recentrage stratégique Innovation Médicale Stratégie Financière Essais Cliniques Oncologie Valerio Therapeutics
Published on 02/07/2026 at 01:00, 14 hours 40 minutes ago Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 16 hours 30 minutes ago Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 17 hours 39 minutes ago Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 1 day ago Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 1 day 2 hours ago Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange
Published on 02/06/2026 at 19:25, 20 hours 14 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 21 hours 47 minutes ago EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG
Published on 02/06/2026 at 17:40, 22 hours ago Carvolix : Nombre d’actions composant le capital social et nombre total de droits de vote au 31.01.26.
Published on 02/06/2026 at 16:55, 22 hours 45 minutes ago GAC MPV Serves as Official Reception Fleet for APEC China 2026, Demonstrating the Strength of Chinese Manufacturing
Published on 02/06/2026 at 15:25, 1 day ago CES 2026 Innovation Award Honoree iGarden M1 Pro Max Launches as World's First Bionic Dual-Vision Pool Cleaner
Published on 02/06/2026 at 18:22, 21 hours 18 minutes ago Déclaration du nombre d’actions et droits de vote au 31 janvier 2026
Published on 02/06/2026 at 18:22, 21 hours 18 minutes ago Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 23 hours 38 minutes ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/06/2026 at 16:01, 23 hours 38 minutes ago Exercice de l’option de remboursement de l'instrument subordonné FR0010093328
Published on 02/06/2026 at 07:54, 1 day 7 hours ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 janvier 2026
